0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Transdermal Drug Patches Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-18M196
Home | Category |Health |Pharmacy |Drugs & Medications
Global Transdermal Drug Patches Market Insights Forecast to 2025

Global Transdermal Drug Patches Market Insights, Forecast to 2025

Code: QYRE-Auto-18M196
Report
May 2019
112 Pages
QYResearch
Region: Global, USA,
Description
Table of Content
Tables & Figures
A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.
Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products. The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.
The global Transdermal Drug Patches market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Drug Patches market based on company, product type, end user and key regions.

This report studies the global market size of Transdermal Drug Patches in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Drug Patches in these regions.
This research report categorizes the global Transdermal Drug Patches market by top players/brands, region, type and end user. This report also studies the global Transdermal Drug Patches market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Noven
    Mylan
    Novartis
    Johnson & Johnson
    Agile Therapeutics
    Teikoku Pharma USA
    Immune Pharmaceuticals
    Hercon Pharmaceuticals
    Pocono
    DURECT Corporation
    Xel Pharmaceuticals

Market size by Product
    Fentanyl Transdermal Patch
    Nicotine Transdermal Patch
    Buprenorphine Transdermal Patch
    Clonidine Transdermal Patch
    Oxybutynin Transdermal Patch
    Others
Market size by End User
    Used for Hypertension
    Used for Contraception
    Used for Analgesia
    Used for Smoking Cessation
    Used for Angina
    Used for Hormone Replacement

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Transdermal Drug Patches market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Transdermal Drug Patches companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Transdermal Drug Patches submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Transdermal Drug Patches are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Drug Patches market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Transdermal Drug Patches Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Transdermal Drug Patches Market Size Growth Rate by Product
        1.4.2 Fentanyl Transdermal Patch
        1.4.3 Nicotine Transdermal Patch
        1.4.4 Buprenorphine Transdermal Patch
        1.4.5 Clonidine Transdermal Patch
        1.4.6 Oxybutynin Transdermal Patch
        1.4.7 Others
    1.5 Market by End User
        1.5.1 Global Transdermal Drug Patches Market Size Growth Rate by End User
        1.5.2 Used for Hypertension
        1.5.3 Used for Contraception
        1.5.4 Used for Analgesia
        1.5.5 Used for Smoking Cessation
        1.5.6 Used for Angina
        1.5.7 Used for Hormone Replacement
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Transdermal Drug Patches Market Size
        2.1.1 Global Transdermal Drug Patches Revenue 2014-2025
        2.1.2 Global Transdermal Drug Patches Sales 2014-2025
    2.2 Transdermal Drug Patches Growth Rate by Regions
        2.2.1 Global Transdermal Drug Patches Sales by Regions
        2.2.2 Global Transdermal Drug Patches Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Transdermal Drug Patches Sales by Manufacturers
        3.1.1 Transdermal Drug Patches Sales by Manufacturers
        3.1.2 Transdermal Drug Patches Sales Market Share by Manufacturers
        3.1.3 Global Transdermal Drug Patches Market Concentration Ratio (CR5 and HHI)
    3.2 Transdermal Drug Patches Revenue by Manufacturers
        3.2.1 Transdermal Drug Patches Revenue by Manufacturers (2014-2019)
        3.2.2 Transdermal Drug Patches Revenue Share by Manufacturers (2014-2019)
    3.3 Transdermal Drug Patches Price by Manufacturers
    3.4 Transdermal Drug Patches Manufacturing Base Distribution, Product Types
        3.4.1 Transdermal Drug Patches Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Transdermal Drug Patches Product Type
        3.4.3 Date of International Manufacturers Enter into Transdermal Drug Patches Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Transdermal Drug Patches Sales by Product
    4.2 Global Transdermal Drug Patches Revenue by Product
    4.3 Transdermal Drug Patches Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Transdermal Drug Patches Breakdown Data by End User

6 North America
    6.1 North America Transdermal Drug Patches by Countries
        6.1.1 North America Transdermal Drug Patches Sales by Countries
        6.1.2 North America Transdermal Drug Patches Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Transdermal Drug Patches by Product
    6.3 North America Transdermal Drug Patches by End User

7 Europe
    7.1 Europe Transdermal Drug Patches by Countries
        7.1.1 Europe Transdermal Drug Patches Sales by Countries
        7.1.2 Europe Transdermal Drug Patches Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Transdermal Drug Patches by Product
    7.3 Europe Transdermal Drug Patches by End User

8 Asia Pacific
    8.1 Asia Pacific Transdermal Drug Patches by Countries
        8.1.1 Asia Pacific Transdermal Drug Patches Sales by Countries
        8.1.2 Asia Pacific Transdermal Drug Patches Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Transdermal Drug Patches by Product
    8.3 Asia Pacific Transdermal Drug Patches by End User

9 Central & South America
    9.1 Central & South America Transdermal Drug Patches by Countries
        9.1.1 Central & South America Transdermal Drug Patches Sales by Countries
        9.1.2 Central & South America Transdermal Drug Patches Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Transdermal Drug Patches by Product
    9.3 Central & South America Transdermal Drug Patches by End User

10 Middle East and Africa
    10.1 Middle East and Africa Transdermal Drug Patches by Countries
        10.1.1 Middle East and Africa Transdermal Drug Patches Sales by Countries
        10.1.2 Middle East and Africa Transdermal Drug Patches Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Transdermal Drug Patches by Product
    10.3 Middle East and Africa Transdermal Drug Patches by End User

11 Company Profiles
    11.1 Noven
        11.1.1 Noven Company Details
        11.1.2 Company Business Overview
        11.1.3 Noven Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Noven Transdermal Drug Patches Products Offered
        11.1.5 Noven Recent Development
    11.2 Mylan
        11.2.1 Mylan Company Details
        11.2.2 Company Business Overview
        11.2.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Mylan Transdermal Drug Patches Products Offered
        11.2.5 Mylan Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Company Business Overview
        11.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Novartis Transdermal Drug Patches Products Offered
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Company Business Overview
        11.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Johnson & Johnson Transdermal Drug Patches Products Offered
        11.4.5 Johnson & Johnson Recent Development
    11.5 Agile Therapeutics
        11.5.1 Agile Therapeutics Company Details
        11.5.2 Company Business Overview
        11.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Agile Therapeutics Transdermal Drug Patches Products Offered
        11.5.5 Agile Therapeutics Recent Development
    11.6 Teikoku Pharma USA
        11.6.1 Teikoku Pharma USA Company Details
        11.6.2 Company Business Overview
        11.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Teikoku Pharma USA Transdermal Drug Patches Products Offered
        11.6.5 Teikoku Pharma USA Recent Development
    11.7 Immune Pharmaceuticals
        11.7.1 Immune Pharmaceuticals Company Details
        11.7.2 Company Business Overview
        11.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Immune Pharmaceuticals Transdermal Drug Patches Products Offered
        11.7.5 Immune Pharmaceuticals Recent Development
    11.8 Hercon Pharmaceuticals
        11.8.1 Hercon Pharmaceuticals Company Details
        11.8.2 Company Business Overview
        11.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Products Offered
        11.8.5 Hercon Pharmaceuticals Recent Development
    11.9 Pocono
        11.9.1 Pocono Company Details
        11.9.2 Company Business Overview
        11.9.3 Pocono Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Pocono Transdermal Drug Patches Products Offered
        11.9.5 Pocono Recent Development
    11.10 DURECT Corporation
        11.10.1 DURECT Corporation Company Details
        11.10.2 Company Business Overview
        11.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 DURECT Corporation Transdermal Drug Patches Products Offered
        11.10.5 DURECT Corporation Recent Development
    11.11 Xel Pharmaceuticals

12 Future Forecast
    12.1 Transdermal Drug Patches Market Forecast by Regions
        12.1.1 Global Transdermal Drug Patches Sales Forecast by Regions 2019-2025
        12.1.2 Global Transdermal Drug Patches Revenue Forecast by Regions 2019-2025
    12.2 Transdermal Drug Patches Market Forecast by Product
        12.2.1 Global Transdermal Drug Patches Sales Forecast by Product 2019-2025
        12.2.2 Global Transdermal Drug Patches Revenue Forecast by Product 2019-2025
    12.3 Transdermal Drug Patches Market Forecast by End User
    12.4 North America Transdermal Drug Patches Forecast
    12.5 Europe Transdermal Drug Patches Forecast
    12.6 Asia Pacific Transdermal Drug Patches Forecast
    12.7 Central & South America Transdermal Drug Patches Forecast
    12.8 Middle East and Africa Transdermal Drug Patches Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Transdermal Drug Patches Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Transdermal Drug Patches Product Picture
    Table Transdermal Drug Patches Market Segments
    Table Key Manufacturers Transdermal Drug Patches Covered
    Table Global Transdermal Drug Patches Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Transdermal Drug Patches Sales Market Share by Product 2014-2025
    Figure Fentanyl Transdermal Patch Product Picture
    Table Major Manufacturers of Fentanyl Transdermal Patch
    Figure Nicotine Transdermal Patch Product Picture
    Table Major Manufacturers of Nicotine Transdermal Patch
    Figure Buprenorphine Transdermal Patch Product Picture
    Table Major Manufacturers of Buprenorphine Transdermal Patch
    Figure Clonidine Transdermal Patch Product Picture
    Table Major Manufacturers of Clonidine Transdermal Patch
    Figure Oxybutynin Transdermal Patch Product Picture
    Table Major Manufacturers of Oxybutynin Transdermal Patch
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Transdermal Drug Patches Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Used for Hypertension
    Figure Used for Contraception
    Figure Used for Analgesia
    Figure Used for Smoking Cessation
    Figure Used for Angina
    Figure Used for Hormone Replacement
    Figure Transdermal Drug Patches Report Years Considered
    Figure Global Transdermal Drug Patches Market Size 2014-2025 (Million US$)
    Figure Global Transdermal Drug Patches Sales 2014-2025 (K Units)
    Table Global Transdermal Drug Patches Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Transdermal Drug Patches Sales by Regions 2014-2019 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share by Regions 2014-2019
    Figure Global Transdermal Drug Patches Sales Market Share by Regions 2014-2019
    Figure 2018 Global Transdermal Drug Patches Sales Market Share by Regions
    Table Global Transdermal Drug Patches Revenue by Regions 2014-2019 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share by Regions 2014-2019
    Figure Global Transdermal Drug Patches Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Transdermal Drug Patches Revenue Market Share by Regions
    Table Global Transdermal Drug Patches Sales by Manufacturers (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by Manufacturers (2014-2019)
    Figure Global Transdermal Drug Patches Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Transdermal Drug Patches Revenue by Manufacturers (2014-2019) (Million USD)
    Table Transdermal Drug Patches Revenue Share by Manufacturers (2014-2019)
    Figure Transdermal Drug Patches Value Share by Manufacturers in 2018
    Table Key Manufacturers Transdermal Drug Patches Price (2014-2019) (USD/Unit)
    Table Transdermal Drug Patches Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Transdermal Drug Patches Product Type
    Table Date of International Manufacturers Enter into Transdermal Drug Patches Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Sales Market Share by Product in 2018
    Table Global Transdermal Drug Patches Revenue by Product (2014-2019) (Million US$)
    Table Global Transdermal Drug Patches Revenue Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Revenue Market Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Revenue Market Share by Product in 2018
    Table Transdermal Drug Patches Price by Product 2014-2019 (USD/Unit)
    Table Global Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by End User (2014-2019)
    Figure Global Sales Transdermal Drug Patches Market Share by End User (2014-2019)
    Figure Global Sales Transdermal Drug Patches Market Share by End User in 2018
    Figure North America Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure North America Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Sales Market Share by Countries
    Table North America Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table North America Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Revenue Market Share by Countries
    Figure United States Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure United States Transdermal Drug Patches Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Market Share by Product
    Table North America Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Market Share by End User
    Figure Europe Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Sales Market Share by Countries
    Table Europe Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Europe Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Revenue Market Share by Countries
    Figure Germany Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure France Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure UK Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Market Share by Product
    Table Europe Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Market Share by End User
    Figure Asia Pacific Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Sales Market Share by Countries
    Table Asia Pacific Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Revenue Market Share by Countries
    Figure China Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure China Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure India Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Market Share by Product
    Table Asia Pacific Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Market Share by End User
    Figure Central & South America Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Sales Market Share by Countries
    Table Central & South America Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Revenue Market Share by Countries
    Figure Brazil Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Market Share by Product
    Table Central & South America Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Market Share by End User
    Figure Middle East and Africa Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Sales Market Share by Countries
    Table Middle East and Africa Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries
    Figure GCC Countries Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Market Share by Product
    Table Middle East and Africa Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Market Share by End User
    Table Noven Company Details
    Table Noven Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Noven Recent Development
    Table Mylan Company Details
    Table Mylan Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Mylan Recent Development
    Table Novartis Company Details
    Table Novartis Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Johnson & Johnson Recent Development
    Table Agile Therapeutics Company Details
    Table Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Agile Therapeutics Recent Development
    Table Teikoku Pharma USA Company Details
    Table Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Teikoku Pharma USA Recent Development
    Table Immune Pharmaceuticals Company Details
    Table Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Immune Pharmaceuticals Recent Development
    Table Hercon Pharmaceuticals Company Details
    Table Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Hercon Pharmaceuticals Recent Development
    Table Pocono Company Details
    Table Pocono Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pocono Recent Development
    Table DURECT Corporation Company Details
    Table DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table DURECT Corporation Recent Development
    Table Xel Pharmaceuticals Company Details
    Table Global Transdermal Drug Patches Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by Regions 2019-2025
    Table Global Transdermal Drug Patches Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share Forecast by Regions 2019-2025
    Table Global Transdermal Drug Patches Sales Forecast by Product 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by Product 2019-2025
    Table Global Transdermal Drug Patches Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share Forecast by Product 2019-2025
    Table Global Transdermal Drug Patches Sales Forecast by End User 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by End User 2019-2025
    Figure North America Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Transdermal Drug Patches Value Chain
    Table Transdermal Drug Patches Customers List
    Table Transdermal Drug Patches Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.
Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products. The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.
The global Transdermal Drug Patches market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Drug Patches market based on company, product type, end user and key regions.

This report studies the global market size of Transdermal Drug Patches in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Drug Patches in these regions.
This research report categorizes the global Transdermal Drug Patches market by top players/brands, region, type and end user. This report also studies the global Transdermal Drug Patches market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Noven
    Mylan
    Novartis
    Johnson & Johnson
    Agile Therapeutics
    Teikoku Pharma USA
    Immune Pharmaceuticals
    Hercon Pharmaceuticals
    Pocono
    DURECT Corporation
    Xel Pharmaceuticals

Market size by Product
    Fentanyl Transdermal Patch
    Nicotine Transdermal Patch
    Buprenorphine Transdermal Patch
    Clonidine Transdermal Patch
    Oxybutynin Transdermal Patch
    Others
Market size by End User
    Used for Hypertension
    Used for Contraception
    Used for Analgesia
    Used for Smoking Cessation
    Used for Angina
    Used for Hormone Replacement

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Transdermal Drug Patches market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Transdermal Drug Patches companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Transdermal Drug Patches submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Transdermal Drug Patches are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Drug Patches market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents

1 Study Coverage
    1.1 Transdermal Drug Patches Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Transdermal Drug Patches Market Size Growth Rate by Product
        1.4.2 Fentanyl Transdermal Patch
        1.4.3 Nicotine Transdermal Patch
        1.4.4 Buprenorphine Transdermal Patch
        1.4.5 Clonidine Transdermal Patch
        1.4.6 Oxybutynin Transdermal Patch
        1.4.7 Others
    1.5 Market by End User
        1.5.1 Global Transdermal Drug Patches Market Size Growth Rate by End User
        1.5.2 Used for Hypertension
        1.5.3 Used for Contraception
        1.5.4 Used for Analgesia
        1.5.5 Used for Smoking Cessation
        1.5.6 Used for Angina
        1.5.7 Used for Hormone Replacement
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Transdermal Drug Patches Market Size
        2.1.1 Global Transdermal Drug Patches Revenue 2014-2025
        2.1.2 Global Transdermal Drug Patches Sales 2014-2025
    2.2 Transdermal Drug Patches Growth Rate by Regions
        2.2.1 Global Transdermal Drug Patches Sales by Regions
        2.2.2 Global Transdermal Drug Patches Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Transdermal Drug Patches Sales by Manufacturers
        3.1.1 Transdermal Drug Patches Sales by Manufacturers
        3.1.2 Transdermal Drug Patches Sales Market Share by Manufacturers
        3.1.3 Global Transdermal Drug Patches Market Concentration Ratio (CR5 and HHI)
    3.2 Transdermal Drug Patches Revenue by Manufacturers
        3.2.1 Transdermal Drug Patches Revenue by Manufacturers (2014-2019)
        3.2.2 Transdermal Drug Patches Revenue Share by Manufacturers (2014-2019)
    3.3 Transdermal Drug Patches Price by Manufacturers
    3.4 Transdermal Drug Patches Manufacturing Base Distribution, Product Types
        3.4.1 Transdermal Drug Patches Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Transdermal Drug Patches Product Type
        3.4.3 Date of International Manufacturers Enter into Transdermal Drug Patches Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Transdermal Drug Patches Sales by Product
    4.2 Global Transdermal Drug Patches Revenue by Product
    4.3 Transdermal Drug Patches Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Transdermal Drug Patches Breakdown Data by End User

6 North America
    6.1 North America Transdermal Drug Patches by Countries
        6.1.1 North America Transdermal Drug Patches Sales by Countries
        6.1.2 North America Transdermal Drug Patches Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Transdermal Drug Patches by Product
    6.3 North America Transdermal Drug Patches by End User

7 Europe
    7.1 Europe Transdermal Drug Patches by Countries
        7.1.1 Europe Transdermal Drug Patches Sales by Countries
        7.1.2 Europe Transdermal Drug Patches Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Transdermal Drug Patches by Product
    7.3 Europe Transdermal Drug Patches by End User

8 Asia Pacific
    8.1 Asia Pacific Transdermal Drug Patches by Countries
        8.1.1 Asia Pacific Transdermal Drug Patches Sales by Countries
        8.1.2 Asia Pacific Transdermal Drug Patches Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Transdermal Drug Patches by Product
    8.3 Asia Pacific Transdermal Drug Patches by End User

9 Central & South America
    9.1 Central & South America Transdermal Drug Patches by Countries
        9.1.1 Central & South America Transdermal Drug Patches Sales by Countries
        9.1.2 Central & South America Transdermal Drug Patches Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Transdermal Drug Patches by Product
    9.3 Central & South America Transdermal Drug Patches by End User

10 Middle East and Africa
    10.1 Middle East and Africa Transdermal Drug Patches by Countries
        10.1.1 Middle East and Africa Transdermal Drug Patches Sales by Countries
        10.1.2 Middle East and Africa Transdermal Drug Patches Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Transdermal Drug Patches by Product
    10.3 Middle East and Africa Transdermal Drug Patches by End User

11 Company Profiles
    11.1 Noven
        11.1.1 Noven Company Details
        11.1.2 Company Business Overview
        11.1.3 Noven Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Noven Transdermal Drug Patches Products Offered
        11.1.5 Noven Recent Development
    11.2 Mylan
        11.2.1 Mylan Company Details
        11.2.2 Company Business Overview
        11.2.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Mylan Transdermal Drug Patches Products Offered
        11.2.5 Mylan Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Company Business Overview
        11.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Novartis Transdermal Drug Patches Products Offered
        11.3.5 Novartis Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Company Business Overview
        11.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Johnson & Johnson Transdermal Drug Patches Products Offered
        11.4.5 Johnson & Johnson Recent Development
    11.5 Agile Therapeutics
        11.5.1 Agile Therapeutics Company Details
        11.5.2 Company Business Overview
        11.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Agile Therapeutics Transdermal Drug Patches Products Offered
        11.5.5 Agile Therapeutics Recent Development
    11.6 Teikoku Pharma USA
        11.6.1 Teikoku Pharma USA Company Details
        11.6.2 Company Business Overview
        11.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Teikoku Pharma USA Transdermal Drug Patches Products Offered
        11.6.5 Teikoku Pharma USA Recent Development
    11.7 Immune Pharmaceuticals
        11.7.1 Immune Pharmaceuticals Company Details
        11.7.2 Company Business Overview
        11.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Immune Pharmaceuticals Transdermal Drug Patches Products Offered
        11.7.5 Immune Pharmaceuticals Recent Development
    11.8 Hercon Pharmaceuticals
        11.8.1 Hercon Pharmaceuticals Company Details
        11.8.2 Company Business Overview
        11.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Products Offered
        11.8.5 Hercon Pharmaceuticals Recent Development
    11.9 Pocono
        11.9.1 Pocono Company Details
        11.9.2 Company Business Overview
        11.9.3 Pocono Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Pocono Transdermal Drug Patches Products Offered
        11.9.5 Pocono Recent Development
    11.10 DURECT Corporation
        11.10.1 DURECT Corporation Company Details
        11.10.2 Company Business Overview
        11.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 DURECT Corporation Transdermal Drug Patches Products Offered
        11.10.5 DURECT Corporation Recent Development
    11.11 Xel Pharmaceuticals

12 Future Forecast
    12.1 Transdermal Drug Patches Market Forecast by Regions
        12.1.1 Global Transdermal Drug Patches Sales Forecast by Regions 2019-2025
        12.1.2 Global Transdermal Drug Patches Revenue Forecast by Regions 2019-2025
    12.2 Transdermal Drug Patches Market Forecast by Product
        12.2.1 Global Transdermal Drug Patches Sales Forecast by Product 2019-2025
        12.2.2 Global Transdermal Drug Patches Revenue Forecast by Product 2019-2025
    12.3 Transdermal Drug Patches Market Forecast by End User
    12.4 North America Transdermal Drug Patches Forecast
    12.5 Europe Transdermal Drug Patches Forecast
    12.6 Asia Pacific Transdermal Drug Patches Forecast
    12.7 Central & South America Transdermal Drug Patches Forecast
    12.8 Middle East and Africa Transdermal Drug Patches Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Transdermal Drug Patches Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures

    Figure Transdermal Drug Patches Product Picture
    Table Transdermal Drug Patches Market Segments
    Table Key Manufacturers Transdermal Drug Patches Covered
    Table Global Transdermal Drug Patches Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Transdermal Drug Patches Sales Market Share by Product 2014-2025
    Figure Fentanyl Transdermal Patch Product Picture
    Table Major Manufacturers of Fentanyl Transdermal Patch
    Figure Nicotine Transdermal Patch Product Picture
    Table Major Manufacturers of Nicotine Transdermal Patch
    Figure Buprenorphine Transdermal Patch Product Picture
    Table Major Manufacturers of Buprenorphine Transdermal Patch
    Figure Clonidine Transdermal Patch Product Picture
    Table Major Manufacturers of Clonidine Transdermal Patch
    Figure Oxybutynin Transdermal Patch Product Picture
    Table Major Manufacturers of Oxybutynin Transdermal Patch
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Transdermal Drug Patches Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Used for Hypertension
    Figure Used for Contraception
    Figure Used for Analgesia
    Figure Used for Smoking Cessation
    Figure Used for Angina
    Figure Used for Hormone Replacement
    Figure Transdermal Drug Patches Report Years Considered
    Figure Global Transdermal Drug Patches Market Size 2014-2025 (Million US$)
    Figure Global Transdermal Drug Patches Sales 2014-2025 (K Units)
    Table Global Transdermal Drug Patches Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Transdermal Drug Patches Sales by Regions 2014-2019 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share by Regions 2014-2019
    Figure Global Transdermal Drug Patches Sales Market Share by Regions 2014-2019
    Figure 2018 Global Transdermal Drug Patches Sales Market Share by Regions
    Table Global Transdermal Drug Patches Revenue by Regions 2014-2019 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share by Regions 2014-2019
    Figure Global Transdermal Drug Patches Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Transdermal Drug Patches Revenue Market Share by Regions
    Table Global Transdermal Drug Patches Sales by Manufacturers (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by Manufacturers (2014-2019)
    Figure Global Transdermal Drug Patches Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Transdermal Drug Patches Revenue by Manufacturers (2014-2019) (Million USD)
    Table Transdermal Drug Patches Revenue Share by Manufacturers (2014-2019)
    Figure Transdermal Drug Patches Value Share by Manufacturers in 2018
    Table Key Manufacturers Transdermal Drug Patches Price (2014-2019) (USD/Unit)
    Table Transdermal Drug Patches Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Transdermal Drug Patches Product Type
    Table Date of International Manufacturers Enter into Transdermal Drug Patches Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Sales Market Share by Product in 2018
    Table Global Transdermal Drug Patches Revenue by Product (2014-2019) (Million US$)
    Table Global Transdermal Drug Patches Revenue Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Revenue Market Share by Product (2014-2019)
    Figure Global Transdermal Drug Patches Revenue Market Share by Product in 2018
    Table Transdermal Drug Patches Price by Product 2014-2019 (USD/Unit)
    Table Global Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Global Transdermal Drug Patches Sales Share by End User (2014-2019)
    Figure Global Sales Transdermal Drug Patches Market Share by End User (2014-2019)
    Figure Global Sales Transdermal Drug Patches Market Share by End User in 2018
    Figure North America Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure North America Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Sales Market Share by Countries
    Table North America Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table North America Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Revenue Market Share by Countries
    Figure United States Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure United States Transdermal Drug Patches Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Market Share by Product
    Table North America Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table North America Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 North America Transdermal Drug Patches Market Share by End User
    Figure Europe Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Sales Market Share by Countries
    Table Europe Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Europe Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Revenue Market Share by Countries
    Figure Germany Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure France Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure UK Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Market Share by Product
    Table Europe Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Europe Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Transdermal Drug Patches Market Share by End User
    Figure Asia Pacific Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Sales Market Share by Countries
    Table Asia Pacific Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Revenue Market Share by Countries
    Figure China Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure China Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure India Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Market Share by Product
    Table Asia Pacific Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Transdermal Drug Patches Market Share by End User
    Figure Central & South America Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Sales Market Share by Countries
    Table Central & South America Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Revenue Market Share by Countries
    Figure Brazil Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Market Share by Product
    Table Central & South America Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Central & South America Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Transdermal Drug Patches Market Share by End User
    Figure Middle East and Africa Transdermal Drug Patches Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Transdermal Drug Patches Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Sales Market Share by Countries
    Table Middle East and Africa Transdermal Drug Patches Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Revenue Market Share by Countries
    Figure GCC Countries Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Transdermal Drug Patches Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Transdermal Drug Patches Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Transdermal Drug Patches Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Market Share by Product
    Table Middle East and Africa Transdermal Drug Patches Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Transdermal Drug Patches Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Transdermal Drug Patches Market Share by End User
    Table Noven Company Details
    Table Noven Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Noven Recent Development
    Table Mylan Company Details
    Table Mylan Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Mylan Recent Development
    Table Novartis Company Details
    Table Novartis Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Johnson & Johnson Recent Development
    Table Agile Therapeutics Company Details
    Table Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Agile Therapeutics Recent Development
    Table Teikoku Pharma USA Company Details
    Table Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Teikoku Pharma USA Recent Development
    Table Immune Pharmaceuticals Company Details
    Table Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Immune Pharmaceuticals Recent Development
    Table Hercon Pharmaceuticals Company Details
    Table Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Hercon Pharmaceuticals Recent Development
    Table Pocono Company Details
    Table Pocono Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pocono Recent Development
    Table DURECT Corporation Company Details
    Table DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table DURECT Corporation Recent Development
    Table Xel Pharmaceuticals Company Details
    Table Global Transdermal Drug Patches Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by Regions 2019-2025
    Table Global Transdermal Drug Patches Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share Forecast by Regions 2019-2025
    Table Global Transdermal Drug Patches Sales Forecast by Product 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by Product 2019-2025
    Table Global Transdermal Drug Patches Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Transdermal Drug Patches Revenue Market Share Forecast by Product 2019-2025
    Table Global Transdermal Drug Patches Sales Forecast by End User 2019-2025 (K Units)
    Table Global Transdermal Drug Patches Sales Market Share Forecast by End User 2019-2025
    Figure North America Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Transdermal Drug Patches Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Transdermal Drug Patches Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Transdermal Drug Patches Value Chain
    Table Transdermal Drug Patches Customers List
    Table Transdermal Drug Patches Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
0 Items
X
No items in the cart.
$0.0